Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Immunothérapie - Vaccinothérapie
Extract
A multicenter, open-label phase I/II trial of the safety and efficacy of the dHER2 recombinant protein combined with immunological adjuvant AS15 in patients with metastatic breast cancer overexpressing HER2/Neu.
Scientific Abstract
en cours d'intégration;